Trials / Completed
CompletedNCT00133107
Safety and Effectiveness of Efalizumab to Treat Oral Lichen Planus
A Single Center, Open-label, Pilot Study Evaluating the Safety and Effectiveness of Subcutaneous Efalizumab in the Treatment of Oral Lichen Planus
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 4 (actual)
- Sponsor
- Washington University School of Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This study is to determine whether efalizumab 1.0mg/kg given by subcutaneous injection for 12 weeks is effective in treating oral lichen planus. This is a 20 week, single center, open-label pilot study to enroll 5 subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | efalizumab |
Timeline
- Start date
- 2005-01-01
- Primary completion
- 2005-11-01
- Completion
- 2005-11-01
- First posted
- 2005-08-22
- Last updated
- 2011-08-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00133107. Inclusion in this directory is not an endorsement.